Xbrane Biopharma AB

40
Sell
  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: SE0007789409
SEK
9.75
0.85 (9.49%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationCash Flow
Xbrane Biopharma AB Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
No of Months
12
12
12
12
12
12
Profit Before Tax
-253.00
-322.00
-168.00
-183.00
-218.00
-187.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
42.00
-119.00
-30.00
-38.00
-18.00
14.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
-133.00
-406.00
-193.00
-219.00
-238.00
-148.00
Cash Flow from Investing Activities
-52.00
-16.00
-60.00
-77.00
-3.00
-1.00
Cash Flow from Financing Activities
243.00
298.00
148.00
349.00
322.00
216.00
Net Cash Inflow / Outflow
58.00
-129.00
-101.00
53.00
78.00
63.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
0.00
-4.00
4.00
1.00
-1.00
-3.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in SEK Million
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Xbrane Biopharma AB
Markets Mojo
Figures in Million
consolidated Cash Flow Results
Markets Mojo
Markets Mojo
Change(SEK)
Change(%)
Profit Before Tax
-253.43
-52.8354692274898
-201.00
-379.66%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
42.267
-4.09387105944449
46.00
1132.45%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
-133.728
-44.6983255149535
-89.00
-199.18%
Cash Flow from Investing Activities
-52.246
-1.51335233545757
-51.00
-3352.34%
Cash Flow from Financing Activities
243.623
41.5213589100213
202.00
486.74%
Net Cash Inflow / Outflow
58.488
-4.69031894038978
62.00
1346.99%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
0.839
0
0.00
0.00%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Dec'24
stock-summary

YoY Growth in year ended Dec 2024 is 67.12% vs -109.72% in Dec 2023

Dec'24
Dec'23
Change(%)
Cash Flow from Operating Activities
-133.73
-406.68
67.12%